Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold Implantation
CTO_BVS
1 other identifier
interventional
34
1 country
1
Brief Summary
Aim of the study is to evaluate chronic total coronary occlusion treatment results 6 years after bioresorbable scaffold implantation by quantitative coronary analysis, intravascular ultrasound and optical coherence tomography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
November 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFirst Posted
Study publicly available on registry
December 11, 2023
CompletedJune 11, 2025
June 1, 2025
6.8 years
November 22, 2023
June 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Target Lesion Failure
Target Lesion Failure (TLF) will be assessed as the number of participants experiencing at least one of the following events during the follow-up period: cardiovascular death, clinically driven target lesion revascularization, target vessel myocardial infarction and stent thrombosis according to the Academic Research Consortium.
6 years
Study Arms (1)
Chronic total coronary occlusion
OTHERParticipants who underwent percutaneous coronary intervention for chronic total coronary occlusion revascularization with bioresorbable scaffold.
Interventions
Revascularization of chronic total coronary occlusion.
Eligibility Criteria
You may qualify if:
- % occlusion of a coronary artery for a duration of greater than or equal to 3 months based on angiographic evidence.
You may not qualify if:
- Participant withdrawal from study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pauls Stradins Clinical University Hospital
Riga, Rīga, LV-1002, Latvia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2023
First Posted
December 11, 2023
Study Start
February 1, 2017
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
June 11, 2025
Record last verified: 2025-06